Hamilton Thorne Ltd., a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, will participate in the Bloom Burton & Co. Healthcare Investor Conference on April 25-26, 2023. David Wolf, President and CEO and Francesco Fragasso, CFO of Hamilton Thorne Ltd., will represent the company at a presentation to be held at the Metro Toronto Convention Center at 9:30 AM EDT on Wednesday, April 26, 2023.

Read the full press release here: Hamilton Thorne to Participate in Bloom Burton & Co. Healthcare Investor Conference on April 25-26, 2023